Urges Japan to honor its commitments under the Market-Oriented Sector-Selective (MOSS) Agreement on Medical Equipment and Pharmaceuticals by: (1) reducing regulatory barriers to the approval and adoption of new medical technologies; (2) meeting or exceeding agency performance goals for premarket approvals and adopting an appropriate, risk-based postmarket system consistent with globally accepted practices; (3) promoting pricing policies that encourage innovation and eliminating reimbursement policies based on inappropriate comparisons to markets outside Japan; (4) implementing fair and open processes and rules that do not disproportionately harm U.S. medical technology products; and (5) providing opportunities for consultation with trading partners.